Product Information
Saypha Volume is a dermal filler that can build volume within the skin to correct skin depressions or wrinkles.
This product is made of highly cross-linked sodium hyaluronate 23mg/ml, sodium chloride, and, phosphate buffer pH 6.8-7.6 q.s.
Saypha Volume is injected into the deep skin layer to help replenish the skin's hyaluronic acid to restore volume to the skin. This volume fills in deep wrinkles and restores volume to sunken areas, and it can even add volume to areas your patient would like to enhance, such as their cheeks and chin. You can use Saypha Volume to correct facial depressions, to correct creases like the nasolabial folds between the nose and mouth, and the marionette lines between the mouth and chin.
Treatment results can last for about six months to a year.
Although the hyaluronic acid in Saypha Volume is purified and sterilized to reduce side effects like granuloma, the injections can still cause light bleeding, temporary tenderness, swelling, bruising, and redness at the injection site. These side effects are usually mild to moderate and disappear within a week. More rarely, Saypha Volume injections can cause the formation of small hematomas, indurations, and lumps which should dissipate with a week.
Your patients can apply an ice pack to the area to soothe swelling they might be experiencing. Use of a local anesthetic can also decrease pain and discomfort. The hyaluronic acid in Saypha Volume has a non-animal origin so it does not require an allergy test before treatment. To reduce the chance of bleeding and bruising, your patients should avoid medications that prolong bleeding, like anti-coagulants and anti-inflammatories, for about a week before treatment. For about a week after the Saypha Volume injection, your patients should avoid sunbathing and high temperatures, and they should not apply any make-up for twelve hours after their treatment. You should not use Saypha Volume on patients who are pregnant or breastfeeding, under eighteen years old, hypersensitive to hyaluronic acid, tend to develop hypertrophic scarring, have a history of auto-immune disease or are receiving immune therapy, or have an inflammation or infection at the site you will be treating.